Clinical Updates in Menopausal Hormone Replacement Therapy: Optimizing Treatment and Hormone Monitoring
This webinar features expert presentations on Menopausal Hormone Replacement Therapy (MHRT) and hormone monitoring from Mark Newman, CEO of Precision Analytical, creators of the DUTCH Test, and Dr. Jaclyn Smeaton, ND and CMO of DUTCH. In Session 1, Dr. Smeaton will provide a clinically oriented overview of the latest research and guidelines for MHRT, with a focus on transdermal estradiol and oral progesterone. She will also highlight the advantages of dried urine testing for monitoring MHRT and discuss how estrogen metabolism can influence health risks. In Session 2, Mark Newman will address common myths about monitoring estradiol and progesterone, comparing the pros and cons of serum, dried urine, and saliva testing. This webinar will also introduce DUTCH’s new MHRT course (available to registered DUTCH Providers) and share findings from recent research, including the impact of 3’,3’-diindolylmethane (DIM) on estrogen metabolism in premenopausal women.
Agenda:
- 5-5:30 pm- Dr. Jeffrey Bland
- 5:30-6pm- Dr. Jaclyn Smeaton, ND on Menopausal Hormone Therapy (MHT) including a clinically oriented overview of current research and new guidelines with a special focus on transdermal estradiol and oral progesterone. This will be followed by an overview of current methods of monitoring MHT with concentration on the significant advantages of dried urine over other body fluids including an overview of how estrogen metabolism might influence risk.
- 6-6:30- Mark Newman- deconstruct some of the myths around monitoring of estradiol and progesterone including the relative advantages and pitfalls associated with using serum, dried urine, and saliva for doing so. Additionally, they’ll increase awareness of the new DUTCH 5-module HRT course available to DUTCH providers. They’ll weave in results from recent DUTCH publications and perhaps find a moment to introduce our new research on 3’,3’-diindolylmethane (DIM) and its effects on estrogen metabolism patterns in premenopausal females.
- 6:30-7pm Panel Q&A with Dr. Jeffrey Bland, Dr. Jaclyn Smeaton, Mark Newman
Hourly Schedule
Feb 4, 2025
- 5:00 pm - 5:30 pm
-
Speakers:
Jeff Bland, PhD
- 5:30 pm - 6:00 pm
- Dr. Jaclyn Smeaton, ND on Menopausal Hormone Therapy (MHT) including a clinically oriented overview of current research and new guidelines with a special focus on transdermal estradiol and oral progesterone. This will be followed by an overview of current methods of monitoring MHT with concentration on the significant advantages of dried urine over other body fluids including an overview of how estrogen metabolism might influence risk.
-
Speakers:
Jaclyn Smeaton, N.D.
- 6:00 pm - 6:30 pm
- deconstruct some of the myths around monitoring of estradiol and progesterone including the relative advantages and pitfalls associated with using serum, dried urine, and saliva for doing so. Additionally, they’ll increase awareness of the new DUTCH 5-module HRT course available to DUTCH providers. They’ll weave in results from recent DUTCH publications and perhaps find a moment to introduce our new research on 3’,3’-diindolylmethane (DIM) and its effects on estrogen metabolism patterns in premenopausal females.
-
Speakers:
Mark Newman, MS
- 6:30 pm - 7:00 pm
- Panel Q&A with Dr. Jeffrey Bland, Dr. Jaclyn Smeaton, Mark Newman
He is known worldwide as the founder of the Functional Medicine movement, which represents his vision for a care model that is grounded in systems biology and informed by research that he has a unique ability to synthesize. His pioneering work has created the Personalized Lifestyle Medicine Institute (PLMI), as well as the Institute for Functional Medicine (IFM), the global leader in Functional Medicine education. Since 1991, hundreds of thousands of healthcare practitioners have participated in PLMI and IFM programs, and this collective knowledge has positively impacted the lives of patients all over the world.
Speakers
-
Jeff Bland, PhDFunctional Medicine Founder and Pioneer
Dr. Jeffrey Bland is a personable and highly respected thought leader who has spent more than four decades focused on the improvement of human health.
He is known worldwide as the founder of the Functional Medicine movement, which represents his vision for a care model that is grounded in systems biology and informed by research that he has a unique ability to synthesize. His pioneering work has created the Personalized Lifestyle Medicine Institute (PLMI), as well as the Institute for Functional Medicine (IFM), the global leader in Functional Medicine education. Since 1991, hundreds of thousands of healthcare practitioners have participated in PLMI and IFM programs, and this collective knowledge has positively impacted the lives of patients all over the world. -
Mark Newman, MSPrecision Analytical Inc.
Mark Newman, MS, is a recognized expert and international speaker in the field of hormone testing. Mark spent nearly 25 years developing and directing 24-hour urine, organic acid, and salivary hormone testing labs. His unique experience led him to pursue a revolutionary way to test hormones. So Mark began his own lab, Precision Analytical Inc., to create the most comprehensive functional hormone test available, DUTCH® (a Dried Urine Test for Comprehensive Hormones). His vision for a better way to test hormones drove Mark to co-write multiple peer-reviewed research papers, which prove the effectiveness and accuracy of dried urine testing to comprehensively evaluate hormone health. Mark is committed to making it easier for patients and their healthcare providers to answer complex clinical questions through extensive education on validated hormone research. Every day, he and his team of experts work toward their mission to profoundly change one life, and then a million more through industry-leading functional hormone testing and education.
-
Jaclyn Smeaton, N.D.
Dr. Jaclyn Smeaton brings extensive experience in the nutrition and wellness space in both practitioner and consumer markets. She specializes in commercial crossover areas including ownership of commercial growth in new product ventures, acquisitions, key strategic customer acquisition and nurture, association, academic and strategic partnerships, business development and marketing functions, ensuring a customer-first approach. Her portfolio includes education, technical writing, product design and innovation, and quality and regulatory practices in manufacturing of dietary supplements, foods, pharmaceuticals, medical devices, and medical foods. Dr. Smeaton brings a uniquely diverse skill set and deep knowledge of the health technology and nutrition markets and a love of marketing and the customer experience. Jaclyn’s unique background includes clinical practice, lab science, extensive teaching and strategic leadership and consulting. She is a sought-after writer for both peer-reviewed journals and lay publications and speaker at national and international conferences, presenting on topics across regulatory affairs, health technology and clinical practice. Dr. Smeaton is very involved in both practitioner and industry groups and has extensive board experience. She has led several nonprofit organizations including President of the American Association of Naturopathic Physicians and the NH Association of Naturopathic Doctors and served as a Trustee for the American Herbal Products Association. During her tenure, she has successfully led efforts to successful adoption of friendly legislation and regulatory guidance, increased association revenue and improved efficiency of the organization allowing for a doubling of association revenue invested in meaningful investment and projects. Dr. Smeaton has also served in numerous roles including Ambassador for the Academy of Integrative Health and Medicine, as a board member of the Integrative Health Policy Consortium and the Institute of Natural Medicine.
Sponsor
